Our MCP (metal coordinated pharmaceutical) technology converts cannabis oil into a fine powder which is not an isolate but a chylomicron of CBDA/CBD/CBN
Synthonics is a biopharmaceutical company that has developed a novel marijuana extraction process that produces 100% cannabinoids without solvents and thus removes the 60% of the unwanted plant materials. More importantly we can convert the CBDA and THCA to CBD and THC. We have also enabled a metallo-CBDA and THCA molecules that we believe will bypass the metabolism of the kidney and have more of the cannabinoid enter into the bloodstream